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Background. Carbon dioxide inhalation is known to induce an emotion similar to spontaneous panic in Panic Disorder
patients. The affective response to carbon dioxide in healthy subjects was not clearly characterized yet. Methodology/
Principal Findings. Sixty-four healthy subjects underwent a double inhalation of four mixtures containing respectively 0, 9,
17.5 and 35% CO2 in compressed air, following a double blind, cross-over, randomized design. Affective responses were
assessed according to DSM IV criteria for panic, using an Electronic Visual Analogue Scale and the Panic Symptom List. It was
demonstrated that carbon dioxide challenges induced a dose dependent negative affect (p,0.0001). This affect was
semantically identical to the DSM IV definition of panic. Older individuals were subjectively less sensitive to Carbon Dioxide
(p,0.05). Conclusions/Significance. CO2 induced affectivity may lay on a continuum with pathological panic attacks.
Consistent with earlier suggestions that panic is a false biological alarm, the affective response to CO2 may be part of
a protective system triggered by suffocation and acute metabolic distress.
Citation: Griez EJ, Colasanti A, van Diest R, Salamon E, Schruers K (2007) Carbon Dioxide Inhalation Induces Dose-Dependent and Age-Related
Negative Affectivity. PLoS ONE 2(10): e987. doi:10.1371/journal.pone.0000987
INTRODUCTION
Intolerance to carbon dioxide in anxiety prone individuals has been
widely documented [1–3]. When inhaling hypercapnic gasses,
subjects diagnosed with Panic Attacks (PA) shortly sense an instant
affect that closely replicates spontaneous panic [4]. Hence Klein
inferred that pathological PA’s may be false biological alarms,
resulting from neuronal misfiring in an evolutionarily evolved, CO2
driven oversensitive suffocation monitor [5].
In other words it was suggested that panic may be an inborn
behavioural response to a metabolic distress. If so, panic mustbelong
to the behavioural repertoire of healthy individuals, the hypersen-
sitive alarm in PD subjects corresponding to a normoresponsive
system in others. Accordingly, the very same mechanism firing false
alarms in PD patients as a response to moderate CO2 intake, should
be activated in healthy subjects following higher doses of CO2.
Here we demonstrate in healthy individuals that increasing
concentrations of CO2 dose dependently induce a negative affect




Sixty-four volunteers provided their informed consent to partic-
ipate in the study. There were 33 males and 31 females, aged 35.8
(SD=15.9) and 31.1 (SD=14.4) years respectively.
All potential participants had a complete inventory of medical
history and a physical examination. Inclusion criteria were 18 to
65 years of age and a good present and past physical and mental
condition. The mental condition was assessed by a structured
psychiatric interview (Mini International Neuropsychiatric In-
terview) performed by a psychologist who was not directly
involved in the study. Exclusion criteria included a history of
pulmonary or cardiovascular disease, the presence of hypertension
(diastolic.100 mmHg; systolic.170 mmHg), cerebral aneurysm,
pregnancy, epilepsy, excessive smoking (.15 cigarettes/day), use
of adrenergic receptor blockers and use of psychotropic medica-
tion. A history of affective or anxiety disorders within a first-degree
relative excluded participation. Participants were also excluded if
they reported common specific fears or if there was any suspicion
of history of Panic Attacks. The ethics committee of the Academic
Hospital of Maastricht approved the study.
Procedure
The inhalation apparatus and the general procedures used in our
laboratory have been described elsewhere [6].
More specifically, the procedure consisted for each subject in
a double inhalation of four mixtures containing respectively 0, 9,
17.5 and 35% CO2 in compressed air, following a double blind
randomized design.
Subjects were instructed in the use of a mask with a demand
valve for self-administration of medical gasses and told that they
would take a double vital capacity breath of four different
concentrations of CO2 in air, which, though being a harmless
physiologic substance, may cause brief neurovegetative responses
and arousal or anxiety, depending on the concentration. Subjects
were asked to exhale to the maximum, to position the inhalation
mask on their face and inhale their full capacity as quickly as
possible. Next they were to empty their lungs and refill them
immediately with gas, whereupon they had to hold their breath for
5 seconds before exhaling. All inhalations took place within one
week, on four separate days but at the same time for each probant.
Care was taken that each inhalation represented at least 80% of
the subject’s vital capacity.
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Affective responses were assessed with strict reference to the DSM
IV (APA, 2000 [7]), which refers to a PA as ‘‘a discrete period of
intense fear or discomfort’’, in which four (or more) out of a list of
thirteen predefined symptoms develop abruptly and reach a peak
within 10 minutes.
Accordingly (Fig. S1) we used an electronic visual analogue scale
for affect (eVAAS). The eVAAS was programmed on a Compaq
Tablet PC, TC1000, with a 21,0 cm616,0 cm touch screen having
a1 0 2 7 6748 pixel resolution. The VAAS was a 20 cm61c m
horizontal bar. Subjects hadtomarktheir anxiety level by tipping on
the bar with a stylus, which had a 1 mm diameter spherical tip. The
top of the display was labelled ‘‘fear or discomfort’’. The scale was
anchored from 0, ‘‘no fear/discomfort at all’’, to 100, ‘‘the worst
imaginable fear/discomfort ’’. This instrument has been validated
for use during 35% CO2 challenges [Van Duinen, M.A., Rickelt, J.,
Griez, E.J.L.. Validation of the eVAAS. 2007 unpublished].
Panic Symptom List (PSL-IV) was used to evaluate panic
symptomatology [8]. It consisted in a questionnaire listing thirteen
items, each item representing a DSM-IV panicsymptom,tobe rated
on a five point scale, from 0 (absent) to 4 (very intense) (Fig. S1).
The eVAAS was presented at baseline immediately before
inhalation, which was followed after CO2 by multiple instant
assessments, in fact as many as possible, during 60 seconds. This
allowed the computation of both a peak value and an area under
the curve (AUC). The Panic Symptom List was administered one
minute before and after each inhalation. The total PSL score was
calculated for each assessment.
Statistical analysis
Statistical analysis was performed on the eVAAS peak values,
obtained by subtracting the baseline from the maximum value, and
PSL total scores, represented by delta scores (post-pre assessment).
A one-way Manova of repeated measures with eVAAS peak
values as the dependent variable and dose (exposure to the four
mixtures of CO2) as the within-subjects factor was used to
investigate the affective response to the various CO2 mixtures. The
same analysis was conducted with eVAAS AUC scores and PSL
individual and total scores as the dependent variables.
AUC was calculated by the trapezoidal rule extrapolation
method. The data were reanalysed using a repeated measures
design with eVAAS peak values or PSL value as the dependent
variable, age (below and above age 38) as a between-subjects factor
and exposure to the four mixtures as the within-subjects factor. In
both analyses, orthogonal polynomial trend contrasts were used to
search for the presence of significant linear and/or quadratic
trends in case of a significant ‘‘dose’’ effect.
Subjects were divided in ‘‘responders’’ and ‘‘non-responders’’,
according to conservative criteria, proposed by others in previous
CO2 challenge studies [9]. Following those criteria an arbitrary
eVAAS peak score of 50 was used as threshold to identify the
responders (mean of the eVAAS peak scored during AIR+2 SD).
In addition responders should report at least one-point increase for
at least four of the 13 PSL symptoms.
RESULTS
Results are presented in figures 1–5.
eVAAS peak values showed CO2-triggered affectivity to be dose
dependent (p,0.001), displaying an increase with concentration,
which fits both a significant linear (p,0.0001) and quadratic
pattern (p,0.001) (Fig. 1 a). eVAAS AUC values were also dose
related (p,0.0001) (Fig. 2 a,b) and exhibited a significant linear
and quadratic pattern (p,0.0001). PSL data yielded similar
results, with comparable dose-response relationship (p,0.0001)
and mathematical pattern (p,0.0001) (Fig. 3 a).
Changes in individual PSL scores symptoms are presented in
Fig. 4. As far as cognitive symptoms are concerned, a PSL score
increase .1 in any of CO2 conditions was shown in 53% of the
subjects.
The sum of the symptom scores, defining a cognitive dimension
(‘‘derealization-depersonalization’’ score+‘‘fear of loosing control-
going crazy’’ score) [10,11] is presented in Fig. 5. Looking to the
cognitive symptoms separately (to which we added fear of dying),
48%, 26%, and 8% of the subjects reported an increase of PSL score
respectively, in any of CO2 condition. A significant CO2 dose-
dependent relationship was evidenced for derealization-depersonal-
ization, and fear of loosing control-going crazy (p,0.0001), which
displayed a linear (p ,0.001) and quadratic pattern (p,0.05). A
similar significant dose-effect was found for fear of dying (p,0.05),
however it appeared to be overall a very rare symptom.
According to above defined criteria there were 4 (6%), 4 (6%), 9
(14%), and 24 (37%) ‘‘responders’’ in the 0, 9, 17.5 and 35% CO2
conditions respectively (p#0.0001).
Figure 1. Peak scores on the Fear/Discomfort scale in four different
CO2 conditions. a) eVAAS: air vs 9% p=0.44; air vs 17.5% and vs 35% p
# 0.001; 9% vs 17.5% and vs 35% p # 0.0001; 17.5% vs 35% p#0.0001.
b) Younger versus older subjects: p,0.05
doi:10.1371/journal.pone.0000987.g001
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group, analysis revealed a significant difference in eVAAS peak
scores (p,0.05) (Fig. 1 b). eVAAS peak values in both age groups
increase in a significant linear (p,0.001) and quadratic pattern
(p,0.001) and run parallel. PSL scores displayed that age effect
was not significant (p=0.217) (Fig. 3 b).
Dividing the subjects by gender, no significant differences were
found between males and females in any of the assessed parameters
(eVAAS peak score, eVAAS AUC score, PSL–IV score).
DISCUSSION
The double breath challenge induced an instant affect with
a negative valence. As rated on the eVAAS, the healthy volunteers
experienced a significant sense of ‘‘fear’’ or ‘‘discomfort’’ while
reporting substantial panic symptomatology on the PSL. Both
eVAAS and PSL were strictly based on DSM-IV semantics. The
picture as a whole was a mathematical function of CO2 intake.
It may therefore be inferred that a double breath of increasing
concentrations of CO2 dose dependently induced a condition
complying with the formal criteria of panic in current psychiatric
nosology.
There has been a wealth of evidence showing that experimental
hypercapnia triggers PA’s in patients diagnosed with PD [1,2,4],
and conditions which are closely related to PD [12,13]. In
contrast, the same procedure failed to affect patients with other
disorders [14], in particular those with Generalized Anxiety
Disorder [15,16], Obsessive-Compulsive Disorder [17,18], Eating
Disorders [19], Major Depression [20] and control groups of
healthy volunteers. First-degree relatives of PD patients however
share a significant degree of CO2 vulnerability [4,21,22]. In fact,
the liability to experience panic with CO2 exposure discriminates
between individuals at high and low risk for PD [3].
Recent reports have suggested that healthy individuals breath-
ing a low 7% concentration of CO2 may display signs of
generalized anxiety [9,23]. Yet, the present results are the first
to demonstrate that CO2 dose dependently activates a condition
identical to panic in healthy volunteers, regardless of any
constitutional predisposition to psychiatric pathology.
Did CO2 induce a true emotion? While formally meeting all the
criteria of a PA according to modern psychiatric nosology, the
CO2 induced state we observed in our healthy subjects may have
Figure 2. Area Under the Curve on the Fear/Discomfort scale in four
different CO2 conditions. a) eVAAS AUC score: air vs 9% p=0.91; air vs
17.5% and vs 35% p # 0.005; 9% vs 17.5% and vs 35% p # 0.001; 17.5%
vs 35% p#0.0001. b) Time course of Fear/Discomfort in a single subject
after the double inhalation of 0%, 9%, 17.5%, 35% CO2 respectively.
doi:10.1371/journal.pone.0000987.g002
Figure 3. Intensity of PSL panic symptoms in four different CO2
conditions. a) PSL: air vs 9% p=0.76; air vs 17.5% and vs 35% p #
0.0001; 9% vs 17.5% and vs 35% p # 0.0001; 17.5% vs 35% p # 0.0001.
b) Younger versus older subjects: p=0.217
doi:10.1371/journal.pone.0000987.g003
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symptoms of hypercapnia and some resulting physical discomfort.
Amongst the 13 PSL items, we therefore separately analyzed the
specific cognitive symptoms of ‘‘derealization’’ and ‘‘fear of loosing
control’’. Several studies have identified these symptoms as
belonging to a specific psychological/cognitive cluster on basis of
factor analysis [10,11]. Our results show that both ‘‘derealization’’
and ‘‘fear of loosing control’’ were linked to the doses of inhaled
carbon dioxide in a significant linear and quadratic pattern. Across
the procedure, ‘‘derealization/depersonalisation’’ displayed more
than one point increase (on a five point scale) in about half of the
subjects, and ‘‘fear of loosing control’’ in about one fourth of them.
Fear of dying did not belong to the cognitive dimension in Meuret
and Cox’s studies [10,11], nevertheless, from a conceptual point of
view, it may refer to an extreme type of emotion. In the present
study ‘‘fear of dying’’ remained very infrequent. However, when
reported, we noted a significant dose-response relationship. It
should be born in mind that all subjects were in a safe laboratory
environment, and all had received ample reassurance regarding
the safety of the intervention trough the informed consent
procedure. This obviously influenced the psychological impact of
CO2. Yet, modest as they are, cognitive shifts did occur, they were
a function of the experimental procedure, and their occurrence
was statistically significant.
This lends support to the idea that, beyond a particular
threshold, carbon dioxide may yield genuine psychotropic
properties in healthy individuals.
Influential authors have increasingly referred to emotions as
evolutionarily derived, ‘‘organism-ready solutions’’ to face major
survival problems [24], as brain representations of internal body
states [25], and more specifically, as images of the ‘‘material me’’
arising from ‘‘the homeostatic condition of each individual’s body’’
[26]. The idea that panic may proceed from a suffocation alarm
disrupted by acute CO2 loading is perfectly consonant with such
views. Several pieces of evidence point to a connection between
hypercapnia and emotion. For instance, it appears that central
chemosensitivity is not restricted to medullary respiratory neurons.
Severson and co-workers [27] have shown that midbrain raphe
serotonergic neurons are CO2 sensors, and midbrain neurons are
not believed to have any direct function in the control of
ventilation. Instead these midbrain chemosensors head mainly in
the rostral direction. They have been proposed to participate in
the homeostasis of the brain via non-respiratory responses to
hypercapnia, including behavioural reactions as hyperarousal and
anxiety [28]. Liotti et al. have produced neuroimaging evidence
linking directly CO2 inhalation with brain structures related to
emotions [29]. Following CO2 induced breathlessness, healthy
volunteers displayed limbic and paralimbic activation, and
neuronal firing in the affective brain correlated with the sense of
suffocation. The authors comment that this neuronal activity may
reflect a primal emotion, in other words ‘‘a compelling in-
teroceptor-driven affect, rooted in metabolic distress, and aimed at
signalling that the existence of the organism is endangered.’’ In an
earlier study on the characteristics of CO2 induced responses,
healthy volunteers spontaneously described their subjective
experience as ‘‘frightening’’, ‘‘panicky’’ or ‘‘scaring’’, while authors
noted that the sensitivity of the feeling, which was poorly
Figure 4. DSM panic symptoms intensity in healthy subjects taking four different doses of CO2.
doi:10.1371/journal.pone.0000987.g004
Figure 5. Aggregate score of cognitive symptoms induced by four
different CO2 conditions in healthy subjects (‘‘derealization-de-
personalization’’ score+ ‘‘fear of loosing control-going crazy’’ score).
doi:10.1371/journal.pone.0000987.g005
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individuals [30].
Our study shows that CO2 intake induces an affective state,
which is similar to the psychiatric picture of panic. Within subjects,
we observe a significant interaction between the intensity of the
affective response and the CO2 concentration of the inhaled
mixture.
We show older subjects to display less behavioural vulnerability
to CO2, compared to younger individuals. To the extent that CO2
intake is a valid model of panic, this difference between younger
and older subjects strikingly evokes the decline of natural PA’s and
the progressive blunting of panic symptomatology in PD patients
when they grow older [31]. Most studies have found a lower
prevalence of PD amongst elderly people [32]. The decreased
CO2 susceptibility in the elderly revealed by the present data
reminds of a similar age effect found with experimental
cholecystokinin provocation of panic [33]. If midbrain serotoner-
gic chemosensors are at work in the chain of events leading from
CO2 to panic, the phenomenon observed in our study might be
related to an age dependent decline of serotonergic activity
[34,35].
No gender differences were found. This is somewhat surprising
in view of all epidemiological data showing women to be at greater
risk for panic than men [36]. Yet, a recent study in a nonclinical
population shows women reporting more fear and panic than men
after CO2 administration [37]. Interestingly, when asked to rate
their experience on a ‘‘like or dislike’’ dimension (which dimension
has a conceptual overlap with ‘‘discomfort’’), the gender difference
disappeared. This suggests women being more prone than men to
report a feeling as ‘‘anxiety’’. Therefore, lumping together anxiety
and discomfort in our eVAAS may have blunted a gender effect. It
is noteworthy that the few existing reports about sex differences in
the so-called condition ‘‘non fearful PD’’, which diagnosis relies on
‘‘discomfort’’ rather than on ‘‘anxiety’’, suggest that both genders
have similar prevalence [38,39].
A final comment applies to the potential of further work with
CO2 challenges in healthy individuals. The panic model of CO2,
in particular the single breath 35% CO2 procedure, has proven to
be both valid and reliable [40]. It has undergone extended
pharmacological validation, e.g. Bertani, Perna et al. [41].
Assuming that higher doses of CO2 activate the same physiologic
chain of events in panic free individuals, CO2 challenges in healthy
volunteers may have a strong potential as a substitute to early
clinical trials in testing novel pharmacological compounds.
In conclusion, it appears that healthy individuals display
a distinct behavioural vulnerability to increasing levels of acute
hypercapnia. This effect is dose-dependent and shares a striking
similarity with the psychiatric condition of panic.
CO2 susceptibility, sensed as acute affective distress may
represent an evolutionarily evolved protective mechanism in case
of impending asphyxia.
SUPPORTING INFORMATION
Figure S1 Experimental assessments. DSM IV TR criteria for
Panic Attack; eVAAS for Fear/Discomfort; Panic Symptom List
(PSL-IV)
Found at: doi:10.1371/journal.pone.0000987.s001 (0.14 MB TIF)
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